This article is intended for primary care clinicians, obstetricians, and other specialists who care for pregnant women at risk for preeclampsia.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 300 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/07. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity. AAFP credit is subject to change based on topic selection throughout the accreditation year.
This Activity is sponsored by Medscape Continuing Education Provider Unit.
Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; None of these credits is in the area of pharmacology.
Provider Number: 6FDKKC-PRV-05
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CME/CE Released: 5/2/2008
Valid for credit through: 5/2/2009, 11:59 PM EST
processing....
May 2, 2008 — Chocolate may decrease the risk for preeclampsia, according to the results of a prospective cohort study reported in the May issue of Epidemiology.
"Preeclampsia is a major pregnancy complication with cardiovascular manifestations," write Elizabeth W. Triche, PhD, from the Yale Center for Perinatal, Pediatric and Environmental Epidemiology in New Haven, Connecticut, and colleagues. "Recent studies suggest that chocolate consumption may benefit cardiovascular health."
The study sample used to evaluate the association of chocolate consumption with the risk for preeclampsia consisted of 2291 pregnant women who delivered a singleton live birth between September 1996 and January 2000.
The investigators measured chocolate consumption by self-report in the first and third trimesters and by umbilical cord serum concentrations of theobromine, which is the main methylxanthine component of chocolate. Detailed medical record review for 1943 of the women allowed determination of preeclampsia. Logistic regression models controlling for potential confounders were used to determine adjusted odds ratios (aOR) and 95% confidence intervals (CIs).
Of 1681 women, preeclampsia developed in 63 (3.7%). Umbilical cord serum theobromine concentrations were inversely associated with preeclampsia (for the highest vs the lowest quartile [aOR, 0.31; CI, 0.11 - 0.87]).
Self-reported estimates of chocolate consumption were also negatively associated with preeclampsia. The risk for preeclampsia was decreased for women consuming 5 or more servings per week vs women consuming less than 1 serving of chocolate weekly (aOR, 0.81; CI, 0.37 - 1.79 for consumption in the first 3 months of pregnancy and aOR, 0.60; CI, 0.30 - 1.24 in the last 3 months).
"Our results suggest that chocolate consumption during pregnancy may lower risk of preeclampsia," the study authors write. "However, reverse causality may also contribute to these findings."
Limitations of this study include difficulty standardizing self-reported chocolate consumption, possible reverse causality if women diagnosed with preeclampsia reduced their calorie intake after diagnosis, possible residual confounding by smoking or body mass index (BMI), small number of women with preeclampsia, and potential misclassification of exposure.
"Because of the importance of preeclampsia as a major complication of pregnancy, replication of these results in other large prospective studies with a detailed assessment of chocolate consumption is warranted," the study authors write. "Measurements of chocolate exposure should be designed to permit careful examination of the temporal relationship between chocolate consumption in pregnancy and subsequent risk of preeclampsia."
The National Institute on Drug Abuse supported this study.
Epidemiology. 2008;19:459-464.
Chocolate contains more than 600 beneficial compounds including flavonoids, magnesium, and theobromine, and recent research suggests that chocolate, particularly dark chocolate, may benefit cardiovascular health. The potent antioxidants in flavonoids can induce nitric oxide–dependent vasodilation and also have antiplatelet and anti-inflammatory effects.
Preeclampsia is a serious maternal complication of pregnancy that shares many characteristics and risk factors for cardiovascular disease. The purpose of this study was to determine whether chocolate consumption is associated with preeclampsia.